BRAVOS for dcSSc (Scleroderma) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults age 18-70 who have been diagnosed with dcSSC for 5 years or less
What is Involved?
If you choose to join this study, you will:
- Be randomized (like flipping a coin) to get the study drug, brentuximab vedotin, or a placebo (an inactive pill)
- Have physical exams, EKGs, and echocardiograms (an ultrasound test of your heart)
- Have a tuberculosis skin test, breathing (pulmonary function) test, and routine blood tests
- Have two skin biopsies